You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 29, 2024

Litigation Details for In re Global Brokerage, Inc. f/k/a FXCM Inc. Securities Litigation (S.D.N.Y. 2017)

✉ Email this page to a colleague

« Back to Dashboard

In re Global Brokerage, Inc. f/k/a FXCM Inc. Securities Litigation (S.D.N.Y. 2017)

Docket	⤷ Try a Trial	Date Filed	2017-02-07
Court	District Court, S.D. New York	Date Terminated	2023-07-07
Cause	15:78m(a) Securities Exchange Act	Assigned To	Ronnie Abrams
Jury Demand	Plaintiff	Referred To	Barbara Moses
Parties	YING ZHAO
Patents	10,154,681; 7,737,112; 9,028,005; 9,102,794
Attorneys	Joshua Evan Baker
Firms	The Rosen Law Firm
Link to Docket	External link to docket

Small Molecule Drugs cited in In re Global Brokerage, Inc. f/k/a FXCM Inc. Securities Litigation

The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .

Biologic Drugs cited in In re Global Brokerage, Inc. f/k/a FXCM Inc. Securities Litigation

The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .

Details for In re Global Brokerage, Inc. f/k/a FXCM Inc. Securities Litigation (S.D.N.Y. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2020-01-06	151	Exhibit 1	73,410 $152 90 $153 00 $0 10 0 07% 737,112 45,909,957 4,590,996 $702,881,442… 52,792 $149 60 $149 70 $0 10 0 07% 737,112 45,909,957 4,590,996 $687,731,156… 105,563 $144 70 $144 80 $0 10 0 07% 737,112 45,909,957 4,590,996 $667,071,675… 81,174 $150 00 $150 10 $0 10 0 07% 737,112 45,909,957 4,590,996 $689,567,554…failed IPO resulting from plaintiff’s claims of patent infringement in genomic industry. Conseco,	External link to document
2020-01-13	152	Exhibit 2	73,410 $152 90 $153 00 $0 10 0 07% 737,112 45,909,957 4,590,996 $702,881,442… 52,792 $149 60 $149 70 $0 10 0 07% 737,112 45,909,957 4,590,996 $687,731,156… 105,563 $144 70 $144 80 $0 10 0 07% 737,112 45,909,957 4,590,996 $667,071,675… 81,174 $150 00 $150 10 $0 10 0 07% 737,112 45,909,957 4,590,996 $689,567,554…failed IPO resulting from plaintiff’s claims of patent infringement in genomic industry. Conseco,	External link to document
2020-04-09	176	Exhibit 1	73,410 $152 90 $153 00 $0 10 0 07% 737,112 45,909,957 4,590,996 $702,881,442… 52,792 $149 60 $149 70 $0 10 0 07% 737,112 45,909,957 4,590,996 $687,731,156… 105,563 $144 70 $144 80 $0 10 0 07% 737,112 45,909,957 4,590,996 $667,071,675… 81,174 $150 00 $150 10 $0 10 0 07% 737,112 45,909,957 4,590,996 $689,567,554…failed IPO resulting from plaintiff’s claims of patent infringement in genomic industry. Conseco,	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.